Vivos TherapeuticsInc Valuation
| VVOS Stock | USD 2.65 0.01 0.38% |
Based on Macroaxis valuation methodology, the company appears to be overvalued. Vivos TherapeuticsInc has a current Real Value of $2.17 per share. The regular price of the company is $2.65. Our model measures the value of Vivos TherapeuticsInc from inspecting the company fundamentals such as Operating Margin of (1.27) %, shares outstanding of 2.98 M, and Return On Equity of -5.21 as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued stocks and selling overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other. Key fundamental drivers impacting Vivos TherapeuticsInc's valuation include:
Price Book 18.9385 | Enterprise Value 7.6 M | Enterprise Value Ebitda (0.49) | Price Sales 0.5705 | Enterprise Value Revenue 0.5895 |
Overvalued
Today
Please note that Vivos TherapeuticsInc's price fluctuation is dangerous at this time. Calculation of the real value of Vivos TherapeuticsInc is based on 3 months time horizon. Increasing Vivos TherapeuticsInc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Vivos TherapeuticsInc is useful when determining the fair value of the Vivos stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Vivos TherapeuticsInc. Since Vivos TherapeuticsInc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vivos Stock. However, Vivos TherapeuticsInc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.65 | Real 2.17 | Target 1.8 | Hype 2.72 |
The real value of Vivos Stock, also known as its intrinsic value, is the underlying worth of Vivos TherapeuticsInc Company, which is reflected in its stock price. It is based on Vivos TherapeuticsInc's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Vivos TherapeuticsInc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Vivos TherapeuticsInc's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Vivos TherapeuticsInc helps investors to forecast how Vivos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vivos TherapeuticsInc more accurately as focusing exclusively on Vivos TherapeuticsInc's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Vivos TherapeuticsInc's intrinsic value based on its ongoing forecasts of Vivos TherapeuticsInc's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Vivos TherapeuticsInc's closest peers. When choosing an evaluation method for Vivos TherapeuticsInc, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Vivos TherapeuticsInc Investments |
|
Vivos Valuation Trend
Knowing Vivos TherapeuticsInc's actual value is paramount for traders to make sound investment determinations. Vivos TherapeuticsInc's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Vivos TherapeuticsInc's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Vivos TherapeuticsInc's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Vivos Market Cap
Vivos TherapeuticsInc is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 9.73 Billion. Vivos TherapeuticsInc adds roughly 7.87 Million in market capitalization claiming only tiny portion of equities under Health Care industry.Vivos TherapeuticsInc Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Vivos TherapeuticsInc's current stock value. Our valuation model uses many indicators to compare Vivos TherapeuticsInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vivos TherapeuticsInc competition to find correlations between indicators driving Vivos TherapeuticsInc's intrinsic value. More Info.Vivos TherapeuticsInc is rated first in price to book category among related companies. It is rated below average in price to sales category among related companies fabricating about 0.03 of Price To Sales per Price To Book. The ratio of Price To Book to Price To Sales for Vivos TherapeuticsInc is roughly 33.20 . At this time, Vivos TherapeuticsInc's Price To Sales Ratio is comparatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Vivos TherapeuticsInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vivos TherapeuticsInc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vivos TherapeuticsInc's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Vivos TherapeuticsInc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Vivos TherapeuticsInc and how it compares across the competition.
About Vivos TherapeuticsInc Valuation
The stock valuation mechanism determines the current worth of Vivos TherapeuticsInc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Vivos TherapeuticsInc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Vivos TherapeuticsInc based exclusively on its fundamental and basic technical indicators. By analyzing Vivos TherapeuticsInc's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Vivos TherapeuticsInc's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vivos TherapeuticsInc. We calculate exposure to Vivos TherapeuticsInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vivos TherapeuticsInc's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 7.7 M | 9.5 M | |
| Pretax Profit Margin | (0.98) | (1.03) | |
| Operating Profit Margin | (1.25) | (1.32) | |
| Net Loss | (0.98) | (1.03) | |
| Gross Profit Margin | 0.55 | 0.77 |
8 Steps to conduct Vivos TherapeuticsInc's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Vivos TherapeuticsInc's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Vivos TherapeuticsInc's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Vivos TherapeuticsInc's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Vivos TherapeuticsInc's revenue streams: Identify Vivos TherapeuticsInc's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Vivos TherapeuticsInc's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Vivos TherapeuticsInc's growth potential: Evaluate Vivos TherapeuticsInc's management, business model, and growth potential.
- Determine Vivos TherapeuticsInc's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Vivos TherapeuticsInc's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Vivos TherapeuticsInc Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Vivos TherapeuticsInc does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.2 M |
Vivos TherapeuticsInc Current Valuation Indicators
Valuation refers to the process of determining the present value of Vivos TherapeuticsInc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Vivos we look at many different elements of the entity such as Vivos's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Vivos TherapeuticsInc's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Vivos TherapeuticsInc's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Vivos TherapeuticsInc, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Vivos TherapeuticsInc's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Vivos TherapeuticsInc's worth.When determining whether Vivos TherapeuticsInc is a strong investment it is important to analyze Vivos TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vivos TherapeuticsInc's future performance. For an informed investment choice regarding Vivos Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivos TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Vivos Stock please use our How to Invest in Vivos TherapeuticsInc guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Vivos Stock analysis
When running Vivos TherapeuticsInc's price analysis, check to measure Vivos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos TherapeuticsInc is operating at the current time. Most of Vivos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Vivos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Vivos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Vivos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos TherapeuticsInc. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.14) | Revenue Per Share 11.318 | Quarterly Revenue Growth (0.18) | Return On Assets (0.88) | Return On Equity (5.21) |
The market value of Vivos TherapeuticsInc is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Vivos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Vivos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.